about
A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases.High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of lifeOral Cyanocobalamin is Effective in the Treatment of Vitamin B12 Deficiency in Crohn's Disease.Inflammatory bowel disease in Digestive Disease Week 2016: advances in epidemiology, follow-up, treatment monitoring, optimisation and individual tailoring, and colon cancer prevention.Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.[Epidemiology, follow-up, monitoring and other aspects of inflammatory bowel disease].Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.[Multiple sclerosis as an adverse effect of anti-tumor necrosis factor agents: an infrequent but important complication of infliximab in Crohn's disease].Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.[Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU.Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study.[Follow-up of patients with inflammatory bowel disease].Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry[Follow-up of patients with inflammatory bowel disease: developments presented at Digestive Disease Week 2014]It is not always Crohn's disease: Amebiasis as a differential diagnosis of inflammatory bowel diseaseBilateral pyoderma gangrenosum associated with ulcerative colitis and restorative proctocolectomySystematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis
P50
Q34612273-04ABC612-6523-47BC-B577-F324604F0491Q37032277-0BEF4258-48BF-4AA0-A2E6-2C98315A87D5Q37729901-A9DF3770-6B2A-4CFA-842B-196F3244E2AFQ39152403-8593D3C8-0FA7-4B26-8F6B-9BF3DC522DEEQ39306418-2A3A9FE8-3D94-439F-B25B-82EF3CD0FDFAQ41163666-9815CD64-800E-40EB-9C09-0A092E58E439Q44144568-375F6821-AC01-4BFB-B4D2-54882192D4FBQ44958336-6348E99F-057F-4607-9156-2D5E44F5E3BFQ48198540-851FE27F-EBB2-4B08-A59C-0D8CD106B84BQ48904882-C5AA435C-CCBE-4588-B849-E2C22E60A4FFQ50456196-1486FB70-BF7C-4B22-A321-9CA8CD59F6B4Q50496615-1C89207F-76D4-459A-9824-3BA36F0B5754Q50567694-E9316DBF-AE9A-404C-AF3D-93243F5D696AQ54668061-B857DE90-E775-4A0E-8041-98D535687748Q57051384-F0082AA2-13D9-4ED6-A261-207EB0E5C318Q85708573-6A9FEBE2-ACDF-48FB-86C6-3105CFDAF101Q92251710-69283B93-ED54-4B51-9A9B-43EC55F6B0DFQ93334973-E1F9C16A-6F2F-4B21-905E-76F10D03CAC6Q93382372-AD751211-D682-4091-B694-D24214C8E3DC
P50
description
investigador
@es
researcher
@en
name
Santiago García-López
@en
type
label
Santiago García-López
@en
prefLabel
Santiago García-López
@en
P31
P496
0000-0003-3970-5457